Bionano Genomics (BNGO) had its price target lowered by HC Wainwright from $7.00 to $6.00. They now have a "buy" rating on the stock.
Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma
Diagens Biotechnology Raises US$101 Million in Hong Kong IPO; Shares More Than Double on First Day of Trading [TheStreet.com]
Bionano Genomics Inc (BNGO) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... [Yahoo! Finance]
Earnings Snapshot: Bionano Genomics beats Q4 top-line but guides Q1, FY25 revenue below estimates [Seeking Alpha]